Ipca Laboratories Limited (NSE:IPCALAB)
India · Delayed Price · Currency is INR 1,905.00
-33.40 (-1.72%)
Nov 12, 2026, 3:29 PM IST
Ipca Laboratories Stock Forecast
Stock Price Forecast
According to 18 analysts polled by S&P Global, Ipca Laboratories stock has a consensus rating of "Buy" and an average price target of ₹2,074. The average 1-year stock price forecast is 8.88% higher than the current stock price, while the lowest is ₹1,731 (-9.13%) and the highest is ₹2,267 (+19.00%).
Price Target: ₹2,074 (+8.88%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Ipca Laboratories stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 9 | 10 | 10 | 11 | 11 | 10 |
| Buy | 5 | 5 | 5 | 4 | 4 | 4 |
| Hold | 1 | 1 | 1 | 2 | 2 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 1 | 0 | 0 | 0 |
| Total | 16 | 17 | 17 | 17 | 17 | 17 |
Financial Forecast
Revenue This Year
110.89B
from 96.47B
Increased by 14.95%
Revenue Next Year
123.66B
from 110.89B
Increased by 11.51%
EPS This Year
59.84
from 46.94
Increased by 27.48%
EPS Next Year
70.98
from 59.84
Increased by 18.63%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.